Document Detail


Outcome of Pregnancy After Exposure to Radioiodine In Utero.
MedLine Citation:
PMID:  21247851     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: Radioiodine (131I) therapy is absolutely contraindicated in pregnancy yet reports of inadvertent exposure continue to appear in the literature. In this review, we discuss the risks of fetal exposure and prevention strategies in the light of current guidelines.Methods: We performed a literature search on MEDLINE using the terms radioiodine, I-131, toxicity, complications and pregnancy and chose the most relevant studies for this review.Results: Before implantation, the major concern is miscarriage and death of the embryo above a radiation threshold of 100mGy (10 rads). Exposure to 131I at this very early stage of pregnancy is unlikely to result in major malformations or thyroid dysfunction in surviving embryos. Exposure later in pregnancy i.e. during thyroidogenesis (from 10 weeks gestation) and organogenesis (from 2 weeks gestation) at similar radiation thresholds may result in fetal thyroid ablation, birth defects and in later life, growth retardation and reduction in IQ. In addition to these deterministic effects, radiation at any dose may increase the risk of cancer (stochastic effect) and recent evidence indicates an increased risk of thyroid cancer many years after in utero exposure.Conclusions: Clinicians treating women of child-bearing age with radioiodine need to be aware of the risks of fetal exposure to radioiodine and take all measures to avoid inadvertent exposure during pregnancy.
Authors:
Steve L Hyer; Brenda Pratt; Kate Newbold; Clive L Hamer
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-17
Journal Detail:
Title:  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists     Volume:  -     ISSN:  1934-2403     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9607439     Medline TA:  Endocr Pract     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-10     Citation Subset:  -    
Affiliation:
Thyroid Unit, Royal Marsden Hospital, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reliability of Early I123 Uptake for the Treatment of Graves' Disease in Children.
Next Document:  Falsely elevated plasma parathyroid hormone (PTH) mimicking tertiary.